CTLA4 and neoplasm: Long-acting repeatable of SSA decrease the level of total regulatory T cells and MDSCs, as well as the expression of PD1, CTLA4 and ENTPD1 in neuroendocrine neoplasms which exert an anti-tumor immunosurveillance function (von Arx et al., 2020).